CHF260.70
0.89% yesterday
SIX Swiss Exchange, Jul 01, 05:31 pm CET
ISIN
CH0012032048
Symbol
ROG
Index
Sector
Industry

Roche Stock price

CHF260.70
-4.00 1.51% 1M
+5.20 2.04% 6M
+5.20 2.04% YTD
+10.60 4.24% 1Y
-59.70 18.63% 3Y
-72.10 21.66% 5Y
-5.60 2.10% 10Y
+98.10 60.33% 20Y
SIX Swiss Exchange, Closing price Tue, Jul 01 2025
+2.30 0.89%
ISIN
CH0012032048
Symbol
ROG
Index
Sector
Industry

Key metrics

Basic
Market capitalization
CHF208.6b
Enterprise Value
CHF225.9b
Net debt
CHF17.3b
Cash
CHF17.3b
Shares outstanding
795.4m
Valuation (TTM | estimate)
P/E
25.26 | 12.41
P/S
3.45 | 3.29
EV/Sales
3.73 | 3.56
EV/FCF
14.98
P/B
6.53
Dividends
DPS
CHF9.70
Yield 1Y | 5Y
3.75% | 3.13%
Growth 1Y | 5Y
1.04% | 1.51%
Payout 1Y | 3Y
93.99% | 72.02%
Increased
25 Years
Financials (TTM | estimate)
Revenue
CHF60.5b | CHF64.2b
EBITDA
CHF20.4b | CHF25.3b
EBIT
CHF20.1b
Net Income
CHF8.3b | CHF16.6b
Free Cash Flow
CHF15.1b
Growth (TTM | estimate)
Revenue
3.03% | 6.12%
EBITDA
8.34% | 23.81%
EBIT
8.41%
Net Income
-28.01% | 100.07%
Free Cash Flow
31.79%
Margin (TTM | estimate)
Gross
73.91%
EBITDA
33.78% | 39.42%
EBIT
33.20%
Net
13.68% | 25.80%
Free Cash Flow
24.94%
Financial Health
Equity Ratio
31.20%
Return on Equity
26.06%
ROCE
26.86%
ROIC
25.49%
Debt/Equity
1.09
More
EPS
CHF10.32
FCF per Share
CHF18.97
Short interest
-
Employees
103.25k
Rev per Employee
CHF590.00k
Show more

Create a Free Account to create an Roche alert.

Set up alerts on Stock Price, Dividend Yield, Valuation (e.g. P/E or EV/Sales) or Strategy Scores and sit back and relax.

Roche Stock Analysis

Unlock Scores for Free

Analyst Opinions

27 Analysts have issued a Roche forecast:

12x Buy
44%
10x Hold
37%
5x Sell
19%

Analyst Opinions

27 Analysts have issued a Roche forecast:

Buy
44%
Hold
37%
Sell
19%

Financial data from Roche

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
60,495 60,495
3% 3%
100%
- Direct Costs 15,783 15,783
1% 1%
26%
44,712 44,712
4% 4%
74%
- Selling and Administrative Expenses 13,758 13,758
2% 2%
23%
- Research and Development Expense 13,042 13,042
1% 1%
22%
20,438 20,438
8% 8%
34%
- Depreciation and Amortization 351 351
4% 4%
1%
EBIT (Operating Income) EBIT 20,087 20,087
8% 8%
33%
Net Profit 8,277 8,277
28% 28%
14%

In millions CHF.

Don't miss a Thing! We will send you all news about Roche directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Roche Stock News

Neutral
Business Wire
2 days ago
MONTREAL--(BUSINESS WIRE)--Lomiko Metals Inc. (TSX.V: LMR) (“Lomiko” or the “Company”) announces exploration results from the spring program at the Ruisseau graphite prospect and plans for the summer/fall exploration and drilling program anticipated in November 2025. Gordana Slepcev, CEO, President, and Director, stated: “We're thrilled to advance our work on the Ruisseau graphite prospect foll...
Neutral
GlobeNewsWire
2 days ago
Basel, 30 June 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that Johannes (Hans) Clevers (1957), M.D., Ph.D., Head of Roche Pharma Research and Early Development (pRED) and member of the enlarged Corporate Executive Committee will be retiring from Roche. Hans Clevers joined the Roche Board of Directors in 2019 and then was appointed Head of Roche pRED in March 2022.
Neutral
Investors Business Daily
6 days ago
President Donald Trump, ever the negotiator, is angling to lower drug prices through his Most Favored Nation policy. But will it work?
More Roche News

Company Profile

Roche Holding AG operates as a research healthcare company. It operates through the following segments: Diagnostics and Pharmaceuticals. The Pharmaceutical segment refers to development of medicines in the field of oncology, immunology, ophthalmology, infectious diseases and neuroscience. The Diagnostic segment refers to diagnosis of diseases through an in vitro diagnostics process. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Head office Switzerland
CEO Thomas Schinecker
Employees 103,249
Founded 1896
Website www.roche.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today